Realtime | Geld | Brief | Zeit |
---|---|---|---|
3,440 | 3,580 | 22:27 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.04. | Zydus Lifesciences Limited Signs Purchase Agreement with PAI Partners and Other Shareholders to Acquire a Majority Stake in Amplitude Surgical SA | 320 | Business Wire | Regulatory News:
Amplitude Surgical SA (Paris:AMPLI):
Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited ("Zydus") and Amplitude Surgical SA (Paris:AMPLI) ("Amplitude")... ► Artikel lesen | |
17.04. | Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates | 233 | Business Wire | Sales up +6.6% at constant exchange rates in Q3 FY 2024-25
Consolidated sales for 9 months up+ 6.4% at constant exchange rates to €83.8m
Good momentum in France: sales up +4.7% over... ► Artikel lesen | |
17.04. | Zydus Lifesciences Limited announces the execution of undertakings to tender as part of its envisaged tender offer for Amplitude Surgical SA shares | 234 | PR Newswire | AHMEDABAD, India and PARIS, April 17, 2025 /PRNewswire/ -- Following the announcement of its envisaged tender offer on March 11, 2025, Zydus Lifesciences Limited announces the execution of... ► Artikel lesen | |
17.04. | Amplitude Surgical Has Been Informed by Zydus Lifesciences Limited of the Execution of Undertakings to Tender as Part of Its Envisaged Tender Offer for Amplitude Surgical SA Shares | 184 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible).
Following the announcement of the envisaged tender offer on March 11, 2025 of Zydus Lifesciences Limited... ► Artikel lesen | |
26.03. | Amplitude Surgical Announces H1 2024-25 Results: 51.5 M€ Sales and 13.1 M€ EBITDA | 297 | Business Wire | Consolidated sales of €51.5m, up 6.3% at constant exchange rates
EBITDA up 10.6% to €13.1 million, EBITDA margin 25.4%
Current operating income of €6.0 million
Cash position... ► Artikel lesen | |
12.03. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 161 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
AMPLITUDE SURGICAL Aktie jetzt für 0€ handeln | |||||
11.03. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 196 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
11.03. | Zydus Life inks pact to acquire majority stake in Amplitude Surgical | 2 | capitalmarket.com | ||
11.03. | Zydus Enters Exclusive Negotiations with PAI Partners and Other Shareholders to Acquire a Majority stake in Amplitude Surgical, France | 313 | Business Wire | Completion of the transaction to be followed by mandatory simplified tender offer
Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical,... ► Artikel lesen | |
20.02. | Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates | 285 | Business Wire | Consolidated sales of €51.5 million, up+ 6.3% at constant exchange rates
Good sales growth in France at +4.6%
Strong growth in international business thanks to subsidiaries, with... ► Artikel lesen | |
21.11.24 | Amplitude Surgical - First Quarter 2024-25: Consolidated Sales of €21.8m, +7.5% at Constant Exchange Rates | 561 | Business Wire | VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics... ► Artikel lesen | |
20.11.24 | Amplitude Surgical Announces Its 2024-25 Financial Calendar | 109 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda... ► Artikel lesen | |
23.10.24 | Amplitude Surgical - Fiscal Year 2023-24: 106.0 M€ Sales and €27.1m EBITDA | 469 | Business Wire | Consolidated sales of €106.0 million, up 6.3% at constant exchange rates
EBITDA up to €27.1m (+3.7%), EBITDA rate at 25.6%.
Current operating income of €12.7 million
Cash... ► Artikel lesen | |
25.07.24 | Amplitude Surgical - Consolidated Annual Sales of €106.0m, up +6.3% at Constant Exchange Rates | 270 | Business Wire | Growth of 7.0% at constant exchange rates in the fourth quarter of FY 2023-2024 and 6.3% for the full year
5.0% sales growth in France
Good momentum outside France, with sales up... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BICO GROUP | 3,188 | -7,00 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
PING AN HEALTHCARE | 0,802 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
ORGANON | 7,958 | +10,47 % | Dividendenbekanntmachungen (12.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AKER BP ASA NO0010345853 6,5173 NOK 0,5586 EUR ALEXANDERS INC US0147521092 4,5 USD 4,0005 EUR AMG CRITICAL MATERIALS NV NL0000888691 0... ► Artikel lesen | |
EMEIS | 10,440 | -3,78 % | emeis: Sales and business to end-March 20251 | Further rise in occupancy rates in France and abroad Occupancy rates growth, particularly in nursing homes (France, Northern Europe, Central Europe) Organic sales growth of +6.2%2, Occupancy... ► Artikel lesen | |
CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
CLARIANE | 3,722 | -1,90 % | Clariane: Minutes of the General Meeting of 14 May 2025 and additional information on the plan to reinforce the financial position | Press release 14 May 2025 Minutes of the General Meeting of 14 May 2025 - additional information on the progress of the plan to reinforce its financial structureParis, 14 May 2025 - The Annual General... ► Artikel lesen | |
ARJO | 2,884 | 0,00 % | Arjo establishes MTN program | ||
M3 INC | 11,600 | -0,85 % | MEDIROM Healthcare Technologies Inc.: M3 Group Joins MEDIROM Mother Labs' Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation | ||
INTERPACE BIOSCIENCES | 0,695 | 0,00 % | Interpace Biosciences GAAP EPS of $0.06, revenue of $11.5B | ||
DYNAVOX GROUP | 8,895 | +0,96 % | DYNAVOX GROUP: Issue and repurchase of class C shares | ||
NYXOAH | 5,460 | +8,55 % | EQS-News: Nyxoah SA.: Nyxoah gibt Finanzergebnisse und operatives Update für das erste Quartal bekannt | EQS-News: Nyxoah SA.
/ Schlagwort(e): Quartalsergebnis
Nyxoah gibt Finanzergebnisse und operatives Update für das erste Quartal bekannt
14.05.2025 / 07:00 CET/CEST
Für... ► Artikel lesen | |
VIVANI MEDICAL | 0,905 | -0,55 % | Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results | All subjects in the NPM-115 cohort had successful insertions of a miniature, ultra long-acting GLP-1 (exenatide) implant in the on-going LIBERATE-1 study in obese or overweight individuals; top-line... ► Artikel lesen | |
NANOSONICS | 2,720 | +1,49 % | NANOSONICS LIMITED: Change of Director's Interest Notice | ||
CHINA MEDICAL SYSTEM | 0,920 | -0,54 % | Dividendenbekanntmachungen (28.04.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEON THANA SINSAP THAILAND PCL NVDR TH0664010R11 2,95 THB 0,0774 EUR BANCO DI DESIO E DELLA BRIANZA SPA IT0001041000 - 0,4566 EUR BRADESPAR... ► Artikel lesen | |
NIAGEN BIOSCIENCE | 9,100 | +0,55 % | ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 | LOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it will... ► Artikel lesen |